Nadège Vimond
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 3
- Immune responses and vaccinations 2
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Nathalie Jacques (5 shared papers)Fanny Billiot (2 shared papers)Philippe Vielh (2 shared papers)A. Laplanche (1 shared paper)Christophe Massard (1 shared paper)Françoise Drusch (1 shared paper)Ludovic Lacroix (1 shared paper)Karim Fizazi (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)British Journal of Cancer (2 papers)Blood Advances (2 papers)Transplantation (2 papers)Clinical and Translational Medicine (1 paper)
- Partner nations
- FranceUnited StatesEstonia
In The Last Decade
Nadège Vimond
16 papers receiving 740 citations
Peers
Comparison fields: 5 of 60
- Oncology 409
- Cancer Research 221
- Hepatology 88
- Immunology 119
- Transplantation 10
Countries citing papers authored by Nadège Vimond
This map shows the geographic impact of Nadège Vimond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Vimond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Vimond more than expected).
Fields of papers citing papers by Nadège Vimond
This network shows the impact of papers produced by Nadège Vimond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Vimond. The network helps show where Nadège Vimond may publish in the future.
Co-authors
The 25 scholars most cited alongside Nadège Vimond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 337 | |
| 2 | 2012 | 112 | |
| 3 | 2019 | 60 | |
| 4 | 2011 | 47 | |
| 5 | 2011 | 41 | |
| 6 | 2008 | 41 | |
| 7 | 2020 | 23 | |
| 8 | 2019 | 21 | |
| 9 | 2022 | 16 | |
| 10 | 2020 | 14 | |
| 11 | 2020 | 12 | |
| 12 | Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome | 2022 | 10 |
| 13 | 2022 | 10 | |
| 14 | 2020 | 2 | |
| 15 | 2026 | 1 | |
| 16 | 2022 | 1 |
About Nadège Vimond
Nadège Vimond is a scholar working on Immunology, Molecular Biology, Oncology, Surgery and Physiology, having authored 16 papers that have together received 748 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Xenotransplantation and immune response (2 papers), Biomedical Ethics and Regulation (2 papers), Immune responses and vaccinations (2 papers), Cancer Cells and Metastasis (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (409 citations), Cancer Research (221 citations), Hepatology (88 citations), Immunology (119 citations) and Transplantation (10 citations). Nadège Vimond has collaborated with scholars based in France, United States and Estonia. Frequent co-authors include Nathalie Jacques, Fanny Billiot, Philippe Vielh, A. Laplanche, Christophe Massard, Françoise Drusch, Ludovic Lacroix, Karim Fizazi, F Farace and David Planchard. Their work appears in journals such as Frontiers in Immunology, British Journal of Cancer, Blood Advances, Transplantation and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.